Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CSA C22.2 No. 60601-2-39-09 (2019) is the Canadian national adoption of IEC 60601-2-39, focusing on the particular safety requirements for peritoneal dialysis equipment. As part of the CSA C22.2 series of standards (Canadian Electrical Code, Part 2), this document ensures that medical electrical equipment used for peritoneal dialysis meets rigorous safety and performance criteria in both clinical and home settings. This article provides an overview of the standard’s scope, key technical requirements, implementation aspects, and compliance pathways.
CSA C22.2 No. 60601-2-39-09 applies to peritoneal dialysis equipment, including automated cyclers, manual exchange devices, and associated accessories that are used for continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD). The standard covers equipment intended for use by healthcare professionals, patients, and caregivers. It modifies and supplements the general requirements of CSA C22.2 No. 60601-1 (IEC 60601-1) to address the unique hazards associated with peritoneal dialysis therapy.
The standard mandates stringent limits for patient leakage currents, protective earth resistance, and dielectric strength. Peritoneal dialysis equipment must maintain patient leakage currents below 10 µA under normal conditions and 50 µA under single-fault conditions. Insulation requirements follow the two means of patient protection (MOPP) and two means of operator protection (MOOP) classification in line with IEC 60601-1 edition 3.
Equipment must control the temperature of infused dialysate within a defined range (typically 35–39 °C) to prevent patient discomfort or injury. Over-temperature protection must be fail-safe, with redundant thermostats or electronic limits. Fluid path materials must be biocompatible and resist chemical degradation from dialysate solutions. The standard also requires alarms for under/over temperature, flow obstruction, and air-in-line detection.
Alarm prioritization is defined in three levels: high priority (e.g., patient disconnect, pump failure), medium priority (e.g., minor occlusion), and low priority (system status). Audible and visual alarms must comply with IEC 60601-1-8, including specific alarm melodies for high priority events. Alarm cancellation shall not reset the underlying alarm condition.
Patient-contacting parts must comply with ISO 10993 series requirements for cytotoxicity, sensitization, and irritation. Sterilization processes (e.g., ethylene oxide, steam) must not leave harmful residues. The standard references CSA C22.2 No. 60601-1 for general biocompatibility considerations.
| Parameter | Requirement / Limit | Test Condition |
|---|---|---|
| Patient leakage current (normal) | ≤ 10 µA | Single fault condition (SFC) |
| Patient leakage current (SFC) | ≤ 50 µA | Single fault condition (SFC) |
| Maximum dialysate temperature | 39 °C (setpoint) with over-temperature alarm at 41 °C | Steady-state flow |
| Alarm response time (high priority) | ≤ 10 seconds from fault detection | As per risk analysis |
| Air-in-line detection threshold | ≤ 0.02 mL for high priority alarm | Verified with calibrated test setup |
| Protective earth resistance | ≤ 0.1 Ω (power cord + internal) | Measured at 10 A, 60 Hz |
| Biocompatibility (cytotoxicity) | Grade 1 or less per ISO 10993-5 | Extract method |
Manufacturers must conduct a thorough risk analysis per CSA C22.2 No. 60601-1 (IEC 60601-1) and ISO 14971. The risk assessment should address hazards including fluid contamination, over-infusion, air embolism, and electrical shock. Residual risks must be reduced to as low as reasonably practicable (ALARP). Safety margins for temperature, pressure, and flow should be justified with test data.
Given that peritoneal dialysis is often performed by patients at home, the standard requires user interface testing per IEC 60601-1-6 (usable design). Specific attention is given to alarms, label clarity, and error prevention during tube connection/disconnection. Formative and summative usability studies are expected.
Type testing must be performed on a single representative unit. Tests include:
All testing must be conducted under worst-case conditions as identified by the risk management process.
To market peritoneal dialysis equipment in Canada, compliance with CSA C22.2 No. 60601-2-39-09 must be demonstrated to an accredited certification body (CB) such as CSA Group, UL, or Intertek. The CB will audit the manufacturer’s quality system (typically ISO 13485) and conduct or witness type testing. Successful certification allows the manufacturer to apply the CSA mark.
The device must be marked with:
Technical documentation must include the risk management file, instructions for use (IFU), test reports, and a declaration of conformity. The IFU must be available in English and French.
© 2026 — All rights reserved.